Articles
Page 2 of 3
-
Citation: Genomic Medicine 2009 2:9081
-
Single gene disorders
Citation: Genomic Medicine 2009 2:9118 -
HGM2008 plenary abstracts: genomics and the future of medicine
Citation: Genomic Medicine 2009 2:9124 -
Pharmacogenomics and toxicogenomics
Citation: Genomic Medicine 2009 2:9123 -
HGM 2008 population genetics and natural selection in man symposium abstracts
Citation: Genomic Medicine 2009 2:9120 -
HGM2008 plenary abstracts: genome functions and systems biology
Citation: Genomic Medicine 2009 2:9119 -
HGM2008 special plenary abstracts
Citation: Genomic Medicine 2009 2:9116 -
Technology developments and applications
Citation: Genomic Medicine 2009 2:9114 -
HGM2008 structural proteomics symposium abstracts
Citation: Genomic Medicine 2009 2:9113 -
Technology developments and applications
Citation: Genomic Medicine 2009 2:9112 -
HGM2008 new technologies: genome sequencing to molecular imaging symposium abstracts
Citation: Genomic Medicine 2009 2:9110 -
Micro RNA and non-coding DNA and repeats
Citation: Genomic Medicine 2009 2:9109 -
Micro RNA and non-coding DNA and repeats
Citation: Genomic Medicine 2009 2:9108 -
HGM2008 infectious diseases and metagenomics symposium abstracts
Citation: Genomic Medicine 2009 2:9106 -
Genomics of complex disorders II
Citation: Genomic Medicine 2009 2:9103 -
Genomics of model organisms
Citation: Genomic Medicine 2009 2:9094 -
Karma, reincarnation, and medicine: Hindu perspectives on biomedical research
Prior to the completion of the Human Genome Project, bioethicists and other academics debated the impact of this new genetic information on medicine, health care, group identification, and peoples’ lives. A ma...
Citation: Genomic Medicine 2009 2:9079 -
Pharmacogenomics and toxicogenomics
Citation: Genomic Medicine 2009 2:9126 -
Genome variation, diversity and evolution
Citation: Genomic Medicine 2009 2:9111 -
Genomics of complex disorders I
Citation: Genomic Medicine 2009 2:9104 -
Genes, chromosomes and disease
Citation: Genomic Medicine 2009 2:9098 -
Single gene disorders
Citation: Genomic Medicine 2009 2:9115 -
Genomics of microbial pathogens and host–pathogen interactions
Citation: Genomic Medicine 2009 2:9101 -
Epigenomics
Citation: Genomic Medicine 2009 2:9099 -
Genome variation, diversity and evolution
Citation: Genomic Medicine 2009 2:9096 -
Genes, chromosomes and disease
Citation: Genomic Medicine 2009 2:9095 -
Epigenomics
Citation: Genomic Medicine 2009 2:9100 -
Genomics of microbial pathogens and host–pathogen interactions
Citation: Genomic Medicine 2009 2:9093 -
Genomics of model organisms
Citation: Genomic Medicine 2009 2:9092 -
Disease proteomics
Citation: Genomic Medicine 2009 2:9090 -
Computational biology and structural proteomics
Citation: Genomic Medicine 2009 2:9089 -
Computational biology and structural proteomics
Citation: Genomic Medicine 2009 2:9088 -
Chemical genomics and molecular medicine
Citation: Genomic Medicine 2009 2:9084 -
Disease proteomics
Citation: Genomic Medicine 2009 2:9091 -
HGM2008 complex disease genomics II symposium abstracts (neuropsychiatric and ocular disorders)
Citation: Genomic Medicine 2009 2:9086 -
HGM2008 cancer and epigenomics symposium abstracts
Citation: Genomic Medicine 2009 2:9083 -
Identification of gene biomarkers for respiratory syncytial virus infection in a bronchial epithelial cell line
Respiratory syncytial virus (RSV) infection involves complex virus-host interplay. In this study, we analyzed gene expression in RSV-infected BEAS-2B cells to discover novel signaling pathways and biomarkers. ...
Citation: Genomic Medicine 2009 2:9080 -
Pharmacogenetics education in British medical schools
Pharmacogenetic tests allow medications to be tailored to individual patients to improve efficacy and reduce drug toxicity. In 2005, the International Society of Pharmacogenomics (ISP) made recommendations for...
Citation: Genomic Medicine 2009 2:9032 -
Association analysis of TNFRSF1B polymorphisms with type 2 diabetes and its related traits in North India
Inflammation plays a crucial role in the pathogenesis of type 2 diabetes and various lines of evidences suggest an important contribution of type 2 receptor for TNFα (TNFR2), a mediator of inflammatory responses....
Citation: Genomic Medicine 2009 2:9031 -
High dose Losartan and ACE gene polymorphism in IgA nephritis
Background/aims Several studies have reported varying results of the influence of ACE gene on ACEI/ARB therapy. The efficacy of high dose ARB and its influence on ACE gene have not been explored. This is a 6 year...
Citation: Genomic Medicine 2009 2:9030 -
Disorders of the genome architecture: a review
Genetic diseases are recognized to be one of the major categories of human disease. Traditionally genetic diseases are subdivided into chromosomal (numerical or structural aberrations), monogenic or Mendelian ...
Citation: Genomic Medicine 2009 2:9028 -
In silico investigations on functional and haplotype tag SNPs associated with congenital long QT syndromes (LQTSs)
Single-nucleotide polymorphisms (SNPs) play a major role in the understanding of the genetic basis of many complex human diseases. It is still a major challenge to identify the functional SNPs in disease-relat...
Citation: Genomic Medicine 2009 2:9027 -
Two sisters with Rett syndrome and non-identical paternally-derived microdeletions in the MECP2 gene
The unique case of two sisters with symptoms of RTT and two quite distinct, novel, and apparently de novo microdeletions of the MECP2 gene is described. One sister possessed an 18 base-pair (bp) deletion (c.1155_...
Citation: Genomic Medicine 2008 2:9026 -
Molecular genetics of myocardial infarction
Myocardial infarction (MI) is an important clinical problem because of its large contribution to mortality. The main causal and treatable risk factors for MI include hypertension, hypercholesterolemia or dysli...
Citation: Genomic Medicine 2008 2:9025 -
Intragenic microdeletion of RUNX2 is a novel mechanism for cleidocranial dysplasia
Cleidocranial dysplasia (CCD; MIM 119600) is a rare autosomal dominant disorder characterized by facial, dental, and skeletal malformations. To date, rearrangement and mutations involving RUNX2, which encodes a t...
Citation: Genomic Medicine 2008 2:9024 -
Association of chromosome 9p21 SNPs with cardiovascular phenotypes in morbid obesity using electronic health record data
Genomic medicine research requires substantial time and resources to obtain phenotype data. The electronic health record offers potential efficiencies in addressing these temporal and economic challenges, but ...
Citation: Genomic Medicine 2008 2:9023 -
Genome mirror 2008
Citation: Genomic Medicine 2008 2:9022 -
The electronic health record as a primary source of clinical phenotype for genetic epidemiological studies
Citation: Genomic Medicine 2008 2:9021 -
Hippocrates revisited? Old ideals and new realities
Individual genomics has arrived, personal decisions to make use of it are a new reality. What are the implications for the patient–physician relationship? In this article we address three factors that call the...
Citation: Genomic Medicine 2008 2:9020 -
A novel computational and structural analysis of nsSNPs in CFTR gene
Single Nucleotide Polymorphisms (SNPs) are being intensively studied to understand the biological basis of complex traits and diseases. The Genetics of human phenotype variation could be understood by knowing ...
Citation: Genomic Medicine 2008 2:9019